Title: AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501
Title: Co-administration with the pharmacological chaperone AT1001 increases recombinant human α-galactosidase A tissue uptake and improves substrate reduction in Fabry mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20120401
Title: The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.
Journal: The Journal of pharmacy and pharmacology 20120101
Title: Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse.
Journal: Gut 20080101
Title: The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.
Journal: Alimentary pharmacology & therapeutics 20070901
Title: Gopalakrishnan S, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 2012 May;35(1):86-94.